Alfred Health
Biological differences between men and women can have an impact on the success of melanoma treatment, according to new research co-led by Alfred oncologist Miles Andrews.
Cancer care for Australians is set to be transformed as building starts on the Paula Fox Melanoma and Cancer Centre at The Alfred.
Victorians at risk of melanoma now have access to cutting-edge 3D whole body imaging, which promises to improve detection and management of the deadly cancer.
“The Alfred Cancer Trials unit is progressive, innovative, supportive, and driven – it’s a dynamic environment to be in, and that’s what excites me.”
“When you have a brain tumour it never ends well. No one can predict how soon it might grow back. You’re dealt the hand your given, then you have to play it the best you can,” said Anthony.
This year, 22-year-old Demi Lawson has not only faced a global pandemic, but a diagnosis of brain cancer, an awake craniotomy (brain surgery) – and has been learning to live with the death of her younger brother.
Alfred Cancer Trials (ACT) has begun testing two new Phase 1 cancer drugs, treating the first patients in the world on these trials.